tiprankstipranks
The Fly

Solventum price target raised to $85 from $80 at BofA

Solventum price target raised to $85 from $80 at BofA

BofA raised the firm’s price target on Solventum (SOLV) to $85 from $80 and keeps a Neutral rating on the shares after the company agreed to sell its Purification & Filtration business to Thermo Fisher (TMO) for $4.1B in cash. Solventum is moving on its multi-year turnaround faster than the firm initially had expected and this transaction will help accelerate the company getting “back on the offense to invest in growth,” the analyst tells investors.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com